Partner with Crescita
Crescita is seeking strategic regional partners to license and distribute its product lines outside of Canada. Business development and collaboration with strategic partners is an important pillar of Crescita’s growth strategy as we continually seek to expand our international reach to further leverage our existing portfolio as well as to add new products and technologies that complement it.
Non-Prescription: Dermacosmetics and Skin Care
Clinically proven quality dermatology products that promote healthy skin. Crescita manufactures substantially all its dermocosmetic products in Canada, relying on Research and Innovation to remain at the forefront of the industry with the highest performing products.
Crescita is strategically seeking qualified partners to market its product lines internationally. To be considered as a distribution partner please contact us at bd@crescitatx.com
Skin Optimizing System that uses state-of-the-art technology and clinically proven ingredients in high concentrations to create a complete skin care solution for patients, helping them achieve healthier, younger-looking skin with visible results.
Renowned for its capacity to offer innovative skin care, Laboratoire Dr Renaud offers exclusive skincare treatments for at home and professional use. It is a comprehensive product line that offers a solution for every skin need.
Specially formulated for rejuvenation, anti-aging and improvement of the most common skin conditions. Contains high quality active ingredients. Often used in combination with or pre & post medical procedures.
Inspired by medico-aesthetic protocols, the entire Premiology skin care line contains the HA4 technology, the result of 20 years of research. This unique technology combines 4 innovative forms of Hyaluronic Acids. HA4 Technology, in an exceptional way, boosts the synthesis of Hyaluronic Acid as well as that of the major proteins of skin rejuvenation for a 360° anti-ageing approach.
Prescription: Pharmaceutical
Pliaglis is a prescription topical local anesthetic cream that provides safe and effective local dermal analgesia on intact skin prior to superficial dermatological procedures. Pliaglis consists of a proprietary formulation of the highest FDA approved concentration of lidocaine 7% and tetracaine 7% that utilizes proprietary phase-changing topical cream Peel technology. Pliaglis is currently available for licensing and distribution in several territories.
Partner with us
Acquisitions & In-Licensing
Crescita is seeking to in-license or acquire commercial or late-stage topical non-prescription and prescription assets for skin conditions as well as fillers, toxins and medical devices for either the aesthetic market or the medical dermatology market.
CMO and CDMO
As a third-party manufacturer of choice, Crescita provides contract manufacturing and contract development services to clients around the world from its 50,000 sqf facility.
Crescita delivers innovative turnkey skincare products integrating production with in-house R&D, supply-chain management, regulatory and quality functions. With over 250 stable formulations, Crescita can help you design, develop and manufacture cosmetic, NHP and dermo-cosmetic product lines of the highest quality from an idea to the shelves.
Crescita’s manufacturing capabilities include: creams, liquids, gels, oils, ointments and serums that can be package into tubes, bottles, vials, capsules and pumps.
Turnkey Solutions
R&D and technology
Needs analysis
Ingredient sourcing
Processing
Packaging
Delivery
To discuss partnering opportunities please contact:
Ivonne Medina
Director, Business Development
bd@crescitatx.com